Systemic characterization of alternative splicing related to prognosis and immune infiltration in malignant mesothelioma

Malignant mesothelioma (MM) is a relatively rare and highly lethal tumor with few treatment options. Thus, it is important to identify prognostic markers that can help clinicians diagnose mesothelioma earlier and assess disease activity more accurately.